TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
BNTX

BioNTech SE

Healthcare · Biotechnology

98.50$ -0.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

BioNTech SE (BNTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 2,757 million EUR. Tick rows to compare them in a chart.

All figures in millions of EUR.

Tick rows to compare them in a chart (up to 4)

Income Statement BNTX
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
62 128 109 482 18,977 17,311 3,819 2,751 2,757
9.3 14 17 59 2,912 2,995 600 541 616
52 114 91 423 16,065 14,316 3,219 2,210 2,140
85 143 227 645 949 1,537 1,783 2,254 2,022
23 24 43 96 277 482 495 531 588
114 168 273 505 781 1,673 2,529 3,524 2,764
-61 -54 -182 -82 15,284 12,643 690 -1,314 -624
0.7 1.8 1.7 1.9 5.6 16 7.8 13 14
-86 -48 -179 -146 15,046 12,954 1,186 -678 -1,009
0.0 0.6 -0.2 -161 4,754 3,520 256 -12 82
-86 -48 -179 15 10,293 9,434 930 -665 -1,091
-75 -24 -144 -105 15,002 13,096 1,377 -367 -628

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?